Moderna seeks FDA authorization for 4th dose of COVID-19 shot

Pfizer's Ceo Albert bourla says 1/4 vaccination would be necessary in order to keep hospitalizations low and illness is mild. In an interview with face the nation bourla explained why it would be important to have a second booster. It is necessary to fourth booster right now. The the protection that you are getting from the third, it is good enough actually, quite good for hospitalizations and deaths is not that good against infections but doesn't last very long. But we are just submitting those data to the FDA and then we'll see what the experts also will say Outside Fighter The Hill reports countries including Israel, chile and Germany have already begun recommending fourth Covid 19 doses for high risk groups, borland said Pfizer is working on creating a vaccine effective against all variants of covid 19 for longer periods of time. What we are trying to do and we are working very diligently right now. It is to make not only a vaccine that will protect against all variants, including, but also something that can protect for at least a year

Related video above: Pfizer CEO Says 4th dose of COVID-19 vaccine will be 'necessary'Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults.The request is broader than rival pharmaceutical company Pfizer's request earlier this week for the regulator to approve a booster shot for all seniors.In a press release, the company said its request for approval for all adults was made "to provide flexibility" to the Centers for Disease Control and Prevention and medical providers to determine the "appropriate use" of a second booster dose of the mRNA vaccine, "including for those at higher risk of COVID-19 due to age or comorbidities."U.S. officials have been laying the groundwork to deliver additional booster doses to shore up the vaccines' protection against serious disease and death from COVID-19. The White House has been sounding the alarm that it needs Congress to "urgently" approve more funding for the federal government to secure more doses of the COVID-19 vaccines, either for additional booster shots or variant-specific immunizations.U.S. health officials currently recommend a primary series of two doses of the Moderna vaccine and a booster dose months later.Moderna said its request for an additional dose was based on "recently published data generated in the United States and Israel following the emergence of Omicron."On Tuesday, Pfizer and its partner BioNTech asked U.S. regulators to authorize an additional booster dose of their COVID-19 vaccine for seniors, saying data from Israel suggests older adults would benefit.

Related video above: Pfizer CEO Says 4th dose of COVID-19 vaccine will be 'necessary'

Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults.

The request is broader than rival pharmaceutical company Pfizer's request earlier this week for the regulator to approve a booster shot for all seniors.

In a press release, the company said its request for approval for all adults was made "to provide flexibility" to the Centers for Disease Control and Prevention and medical providers to determine the "appropriate use" of a second booster dose of the mRNA vaccine, "including for those at higher risk of COVID-19 due to age or comorbidities."

U.S. officials have been laying the groundwork to deliver additional booster doses to shore up the vaccines' protection against serious disease and death from COVID-19. The White House has been sounding the alarm that it needs Congress to "urgently" approve more funding for the federal government to secure more doses of the COVID-19 vaccines, either for additional booster shots or variant-specific immunizations.

Ted S. Warren / AP File Photo

A vial of the Moderna COVID-19 vaccine

U.S. health officials currently recommend a primary series of two doses of the Moderna vaccine and a booster dose months later.

Moderna said its request for an additional dose was based on "recently published data generated in the United States and Israel following the emergence of Omicron."

On Tuesday, Pfizer and its partner BioNTech asked U.S. regulators to authorize an additional booster dose of their COVID-19 vaccine for seniors, saying data from Israel suggests older adults would benefit.

��vlog